Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
Aliment Pharmacol Ther
; 54(10): 1320-1329, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34472644
Full text:
1
Database:
MEDLINE
Main subject:
Pregnancy Outcome
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Newborn
/
Pregnancy
Language:
En
Year:
2021
Type:
Article